Migraine procedure trial pulled before it even started
NCT ID NCT07044648
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study aimed to see if blocking a specific artery in the brain could help people with chronic migraines that don't respond to drugs. The procedure, called middle meningeal artery embolization, uses tiny particles or coils to block the vessel. However, the study was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Middle meningeal artery embolization (a procedure using particles or coils to block a blood vessel in the brain)
What this could lead to
If it works, this could offer a new treatment option for people with chronic migraines that don't improve with medication.
What could go wrong
This trial was withdrawn before any participants were enrolled, so no data exists. The procedure is invasive and carries risks like bleeding or stroke.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.